Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
|---|---|---|---|
| Operating cash flow (direct method) | |||
| Cash income from operating activities | |||
| Cash paid | -149.59%-782.56K | 21.56%-313.54K | -399.72K |
| Payments to suppliers for goods and services | -149.59%-782.56K | 21.56%-313.54K | ---399.72K |
| Direct interest paid | ---4.34K | ---- | ---- |
| Direct interest received | 52.21%173.58K | 34.00%114.04K | --85.1K |
| Direct tax refund paid | ---65.31K | ---- | ---- |
| Operating cash flow | -240.17%-678.63K | 36.59%-199.5K | ---314.62K |
| Investing cash flow | |||
| Cash flow from continuing investing activities | 185.25%1.71M | -39.60%-2M | -1.43M |
| Capital expenditure reported | 21.28%-1.89M | -43.89%-2.41M | ---1.67M |
| Net PPE purchase and sale | 785.89%3.6M | 3,464.85%406.37K | ---12.08K |
| Net business purchase and sale | ---- | ---- | --251.71K |
| Cash from discontinued investing activities | |||
| Investing cash flow | 185.25%1.71M | -39.60%-2M | ---1.43M |
| Financing cash flow | |||
| Cash flow from continuing financing activities | -25.57%-52.91K | -100.68%-42.14K | 6.16M |
| Net issuance payments of debt | ---- | ---- | ---10.44K |
| Net common stock issuance | ---10.5K | ---- | --6.17M |
| Net other financing activities | -0.65%-42.41K | ---42.14K | ---- |
| Cash from discontinued financing activities | |||
| Financing cash flow | -25.57%-52.91K | -100.68%-42.14K | --6.16M |
| Net cash flow | |||
| Beginning cash position | -50.80%2.17M | --4.41M | ---- |
| Current changes in cash | 143.43%973.75K | -150.80%-2.24M | --4.41M |
| End cash Position | 44.84%3.15M | -50.80%2.17M | --4.41M |
| Free cash from | 2.50%-2.57M | -32.00%-2.64M | ---2M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |